Trial comparisons

curl "https://conductscience.org/api/comparisons/v1?page=219"

Response

The first 2 of this page's 20 results. GET /api/comparisons/v1?page=219

{
  "data": {
    "total": 85013,
    "results": [
      {
        "id": "NCT00077636-sae",
        "title": "PEG-IFN Alfa-2a 180μg + Ribavirin 800 mg 16 Weeks vs PEG-IFN Alfa-2a 180μg + Ribavirin 800 mg 24 Weeks: serious adverse events",
        "summary": "34 of 731 against 47 of 728; risk difference -1.8 points, 95% interval -4.2 to 0.6; NCT00077636, ACCELERATE Study - A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Combination With COPEGUS (Ribavirin) in Interferon-Naive Patients With Chronic Hepatitis C (CHC) Infection.",
        "record": "/library/comparisons/NCT00077636-sae",
        "nct_id": "NCT00077636",
        "kind": "serious-adverse-events",
        "participants": 1459,
        "risk_difference": {
          "value": -0.018048811653462823,
          "lower": -0.04212204793002142,
          "upper": 0.005647801556671741
        },
        "group_1": "34 of 731",
        "group_2": "47 of 728",
        "difference": "-1.8 points",
        "interval": "-4.2 to 0.6",
        "trial_title": "ACCELERATE Study - A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Combination With COPEGUS (Ribavirin) in Interferon-Naive Patients With Chronic Hepatitis C (CHC) Infection."
      },
      {
        "id": "NCT02646423-b8156f04",
        "title": "Prior CD Decision App (PCDDA) vs Usual Care - No App: Number of Participants Who Underwent a Trial of Labor After Cesarean (TOLAC) Delivery",
        "summary": "315 of 727 against 338 of 732; risk difference -2.8 points, 95% interval -7.9 to 2.3; NCT02646423, Effect of a Patient-Centered Decision App on TOLAC",
        "record": "/library/comparisons/NCT02646423-b8156f04",
        "nct_id": "NCT02646423",
        "kind": "outcome",
        "participants": 1459,
        "risk_difference": {
          "value": -0.028461151073729152,
          "lower": -0.0792318307802696,
          "upper": 0.022522003896597087
        },
        "group_1": "315 of 727",
        "group_2": "338 of 732",
        "difference": "-2.8 points",
        "interval": "-7.9 to 2.3",
        "trial_title": "Effect of a Patient-Centered Decision App on TOLAC"
      }
    ],
    "no_events": 33758,
    "columns": [
      {
        "key": "title",
        "label": "Comparison"
      },
      {
        "key": "group_1",
        "label": "With the outcome",
        "under": "group_2"
      },
      {
        "key": "difference",
        "label": "Risk difference, 95% interval",
        "under": "interval"
      },
      {
        "key": "participants",
        "label": "Participants"
      },
      {
        "key": "nct_id",
        "label": "Trial",
        "under": "trial_title"
      }
    ],
    "order": "Most participants first",
    "kinds": {
      "all": 85013,
      "outcome": 33568,
      "serious-adverse-events": 31897,
      "deaths": 19548
    }
  },
  "release": "trial-comparisons-2026-03-23-0.1.0",
  "terms": [
    {
      "source": "ClinicalTrials.gov's posted results, through CTTI's AACT",
      "license": "ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299",
      "notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.",
      "short": "Freely available. Acknowledgement requested"
    },
    {
      "source": "ClinicalTrials.gov",
      "license": "none stated",
      "notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.",
      "short": "No license stated"
    }
  ],
  "next": "/api/comparisons/v1?page=220",
  "request_id": "T7be9xnJTx8gniHD"
}